India's intranasal COVID vaccine, "Incovacc", launched to the mass population this week. The cost is $13 Canadian dollars per dose. (Pretty high for a population that size, IMHO.) Itching to see surveillance data in a few months. Will it dramatically reduce transmission?
Follow
@deonandan Very much been waiting to see how this goes and if there's any good data on this eventually.
